ecansya 150 mg/1 tableta filmom obložena tableta
krka farma d.o.o. sarajevo - kapecitabin - filmom obložena tableta - 150 mg/1 tableta - 1 filmom obložena tableta sadrži: 150 mg kapecitabin
ecansya 300 mg/1 tableta filmom obložena tableta
krka farma d.o.o. sarajevo - kapecitabin - filmom obložena tableta - 300 mg/1 tableta - 1 filmom obložena tableta sadrži: 300 mg kapecitabin
ecansya 300 mg/1 tableta filmom obložena tableta
krka farma d.o.o. sarajevo - kapecitabin - filmom obložena tableta - 300 mg/1 tableta - 1 filmom obložena tableta sadrži: 300 mg kapecitabin
ecansya 300 mg/1 tableta filmom obložena tableta
krka farma d.o.o. sarajevo - kapecitabin - filmom obložena tableta - 300 mg/1 tableta - 1 filmom obložena tableta sadrži: 300 mg kapecitabin
ecansya 300 mg/1 tableta filmom obložena tableta
krka farma d.o.o. sarajevo - kapecitabin - filmom obložena tableta - 300 mg/1 tableta - 1 filmom obložena tableta sadrži: 300 mg kapecitabin
ecansya 500 mg/1 tableta filmom obložena tableta
krka farma d.o.o. sarajevo - kapecitabin - filmom obložena tableta - 500 mg/1 tableta - 1 filmom obložena tableta sadrži: 500 mg kapecitabin
ecansya 500 mg/1 tableta filmom obložena tableta
krka farma d.o.o. sarajevo - kapecitabin - filmom obložena tableta - 500 mg/1 tableta - 1 filmom obložena tableta sadrži: 500 mg kapecitabin
ecansya 500 mg/1 tableta filmom obložena tableta
krka farma d.o.o. sarajevo - kapecitabin - filmom obložena tableta - 500 mg/1 tableta - 1 filmom obložena tableta sadrži: 500 mg kapecitabin
ecansya 500 mg/1 tableta filmom obložena tableta
krka farma d.o.o. sarajevo - kapecitabin - filmom obložena tableta - 500 mg/1 tableta - 1 filmom obložena tableta sadrži: 500 mg kapecitabin
lonsurf
les laboratoires servier - trifluridine, tipiracil hidroklorid - kolorektalne neoplazme - antineoplastična sredstva - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.